Riding the Trend or Protecting Profits | Frequency Therapeutics Inc. (FREQ) – News Heater
Home  »  Companies   »  Riding the Trend or Protecting Profits | Frequency...

Riding the Trend or Protecting Profits | Frequency Therapeutics Inc. (FREQ)

Frequency Therapeutics Inc. (NASDAQ:FREQ) went up by 10.24% from its latest closing price compared to the recent 1-year high of $10.90. The company’s stock price has collected 12.00% of gains in the last five trading sessions.

Is It Worth Investing in Frequency Therapeutics Inc. (NASDAQ :FREQ) Right Now?

Opinions of the stock are interesting as 3 analysts out of 5 who provided ratings for Frequency Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 1 as “sell.”

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored

FREQ currently public float of 32.21M and currently shorts hold a 4.84% ratio of that float. Today, the average trading volume of FREQ was 652.88K shares.

FREQ’s Market Performance

FREQ stocks went up by 12.00% for the week, with a monthly jump of 0.36% and a quarterly performance of -71.13%, while its annual performance rate touched -86.55%. The volatility ratio for the week stands at 12.23% while the volatility levels for the past 30 days are set at 14.20% for Frequency Therapeutics Inc.. The simple moving average for the period of the last 20 days is -2.91% for FREQ stocks with a simple moving average of -72.90% for the last 200 days.

Analysts’ Opinion of FREQ

Many brokerage firms have already submitted their reports for FREQ stocks, with Goldman repeating the rating for FREQ by listing it as a “Neutral.” The predicted price for FREQ in the upcoming period, according to Goldman is $9 based on the research report published on September 22nd of the previous year 2021.

JP Morgan, on the other hand, stated in their research note that they expect to see FREQ reach a price target of $56. The rating they have provided for FREQ stocks is “Overweight” according to the report published on January 27th, 2021.

B. Riley Securities gave a rating of “Buy” to FREQ, setting the target price at $79 in the report published on December 22nd of the previous year.

FREQ Trading at -25.39% from the 50-Day Moving Average

After a stumble in the market that brought FREQ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -87.16% of loss for the given period.

Volatility was left at 14.20%, however, over the last 30 days, the volatility rate increased by 12.23%. Over the last 50 days, in opposition, the stock is trading -50.70% lower at present.

During the last 5 trading sessions, FREQ rose by +12.00%, which changed the moving average for the period of 200-days by -81.96% in comparison to the 20-day moving average, which settled at $1.4420. In addition, Frequency Therapeutics Inc. saw -72.71% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at FREQ starting from Loose Christopher R., who sale 1,069 shares at the price of $3.53 back on Feb 22. After this action, Loose Christopher R. now owns 34,827 shares of Frequency Therapeutics Inc., valued at $3,774 using the latest closing price.

LeBel Carl, the Chief Development Officer of Frequency Therapeutics Inc., sale 1,069 shares at $3.53 during a trade that took place back on Feb 22, which means that LeBel Carl is holding 11,126 shares at $3,773 based on the most recent closing price.

Stock Fundamentals for FREQ

Current profitability levels for the company are sitting at:

  • -597.32 for the present operating margin
  • +72.70 for the gross margin

The net margin for Frequency Therapeutics Inc. stands at -601.98.

The liquidity ratio also appears to be rather interesting for investors as it stands at 11.79.

Leave a Comment

Your email address will not be published.

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam